bertilimumab human monoclonal antibody binds important regulator overall eosinophil function discovered cambridge antibody technology using phage display named early discovery development cat used treat severe allergic january cat licensed drug treatment allergy disorders ico therapeutics ico therapeutics inc vancouverbased reprofiling company focused redosing reformulating drugs clinical history new expanded indications socalled search development ico therapeutics inc renamed drug stage planned initiate phase ii clinical trial patients vernal march ico announced patients phase ii clinical trials drug substance manufactured lonza cgmp facilities slough uk subsequently ico moved drug substance fillfinish site final stage manufacturing ico reported drug product within specifications contained high antibody immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding ithttpsenwikipediaorgwikibertilimumab